The National Functional Genomics Center (NFGC) will validate the concept that molecular signatures in tumors predict cancer risk, diagnosis, prognosis, and response to therapy, as well as identify new molecular targets for the development of more effective cancer prevention and personalized therapeutic care.
Srikumar Chellappan, PhD
Principal Investigator and Scientific Director
National Functional Genomics Center
Senior Member and Chair,
Department of Tumor Biology
H. Lee Moffitt Cancer Center & Research Institute
"The NFGC is designed to bridge the gap between pure science and patient care by stimulating translational cancer research that will make a real difference in how we diagnose the disease and how we treat it."